Moreover, SINX can significantly reduce the levels of pro-inflammatory factors (TNF-α, IL-1β, IL-6) secreted by RA-FLS in vitro, which mediate synovial inflammation and activate osteoclasts. The gene discussed is IL1B; the disease is rheumatoid arthritis.